Philippines - English - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - live attenuated canine parvovirus (cpv) , canine distemper virus (cdv) , canine adenovirus type 2 (cav 2) , canine parainfluenza (cpiv) vaccine , leptospira interrogans ser. icterohaemorrhagiae , l. interrogans ser. canicola vaccine (vet.) - freeze dried powder for injection (sc) - formulation: each ml of reconstituted vaccine (dose) contains: canine parvovirus (c-780916 strain)......>10^6 tcid50 canine distemper virus (lederle strain)...........>10^4 tcid50 canine adenovirus type 2 (manhattan strain)............>10^4 tcid50 canine parainfluenza virus (cpiv) (penn 103/70 strain)....... ......>10^5 tcid50 leptospira interrogans ser. icterohaemorrhagiae..........>10^9 microorganisms leptospira interrogans ser. canicola.................. >10^9 microorganisms tcid-tissue culture infective dose

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: hipra philippines, inc.; distributor: hipra philippines, inc. - live attenuated canine parvovirus (cpv) , canine distemper virus (cdv) , canine adenovirus type 2 (cav 2) , canine parainfluenza (cpiv) vaccine , leptospira interrogans ser. icterohaemorrhagiae , l. interrogans ser. canicola vaccine (vet.) - freeze dried powder for injection (sc) - formulation: each ml of reconstituted vaccine (dose) contains: canine parvovirus (c-780916 strain)......>10^6 tcid50 cani

New Zealand - English - Ministry for Primary Industries

virbac new zealand limited - canine parvovirus (attenuated); canine adenovirus type 2 (attenuated); canine parainfluenza virus (attenuated); canine distemper virus (attenuated) - canine parvovirus (attenuated) 0 vaccine; canine adenovirus type 2 (attenuated) 0 vaccine; canine parainfluenza virus (attenuated) 0 vaccine; canine distemper virus (attenuated) 0 vaccine - vaccine

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - canine parvovirus (attenuated); canine distemper virus (attenuated) - canine parvovirus (attenuated) 0 vaccine; canine distemper virus (attenuated) 0 vaccine - vaccine

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 8–9 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagie serovar icterohaemorrhagiae,to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa and to prevent mortality, clinical signs and infection caused by rabies virus.

Ireland - English - HPRA (Health Products Regulatory Authority)

merial animal health limited - canine distemper virus, live, canine adenovirus type 2, live, canine parvovirus, live, canine parainfluenza virus, live - lyophilisate and solvent for solution for injection - unknown - canine distemper virus vaccine + canine adenovirus vaccine + canine parvovirus vaccine + canine para - canine - immunological - live vaccine

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 6 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae and to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa.

Ireland - English - HPRA (Health Products Regulatory Authority)

merial animal health limited - canine parvovirus attenuated - lyophilisate for suspension - unknown - canine parvovirus vaccine - canine - immunological - live vaccine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - canine adeno virus type 2; canine distemper virus - living; canine parainfluenza virus; canine parvo virus type 2 - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 u; canine distemper virus - living vaccine-viral active 0.0 u; canine parainfluenza virus vaccine-viral active 0.0 u; canine parvo virus type 2 vaccine-viral active 0.0 u - immunotherapy - dog | bitch | castrate | puppy - canine distemper | canine parainfluenza | canine parvovirus | hepatitis :- infectious | canine adenovirus type 1 | canine adenovirus type 2 | infectious canine hepatitis | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - canine adeno virus type 2; canine distemper virus; canine parvo virus - parenteral liquid/solution/suspension - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog | bitch | castrate | puppy - canine distemper | canine parvovirus | hepatitis :- infectious | vaccine | canine adenovirus type 1 | canine adenovirus type 2 | equine rotavirus | infectious canine hepatitis | parvovirus